RACK7 recognizes H3.3G34R mutation to suppress expression of MHC class II complex components and their delivery pathway in pediatric glioblastoma

Journal: Science Advances

Published: 2020-07-01

DOI: 10.1126/sciadv.aba2113

Affiliations: 21

Authors: 18

Go to article
Institutions Share
Shanghai Medical College (SHMC), Fudan University, China 0.20
St. Jude Children's Research Hospital (St. Jude), United States of America (USA) 0.11
Huashan Hospital, Fudan University, China 0.11
Shanghai Key Laboratory of Medical Epigenetics, Fudan University, China 0.11
MST International Co-Laboratory of Medical Epigenetics and Metabolism, Fudan University, China 0.09
Shanghai Pudong Hospital, Fudan University, China 0.07
Boston Children's Hospital (BCH), United States of America (USA) 0.06
Harvard University, United States of America (USA) 0.06
Brigham and Women's Hospital (BWH), United States of America (USA) 0.06
The Institute of Cancer Research (ICR), United Kingdom (UK) 0.06
Fudan University, China 0.04
Fudan University Shanghai Cancer Center (FUSCC), China 0.02
State Key Laboratory of Genetic Engineering, Fudan University, China 0.02
MOE Key Laboratory of Carcinogenesis and Cancer Invasion, China 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER